Literature DB >> 26063743

Echocardiographic and Hemodynamic Predictors of Survival in Precapillary Pulmonary Hypertension: Seven-Year Follow-Up.

Julia Grapsa1, Maria Carmo Pereira Nunes1, Timothy C Tan1, Ines Zimbarra Cabrita1, Taryn Coulter1, Benjamin C F Smith1, David Dawson1, J Simon R Gibbs1, Petros Nihoyannopoulos2.   

Abstract

BACKGROUND: In this study, we looked at the prognostic value of echocardiographic and hemodynamic measures in a large cohort of patients with precapillary pulmonary hypertension before and after initiation of treatment. METHODS AND
RESULTS: Data were collected prospectively in a cohort of consecutive patients with precapillary pulmonary hypertension referred between 2002 and 2011. A range of clinical and echocardiographic variables were collected and stored on a database to assess predictors of survival. Invasive hemodynamic data including pulmonary artery pressure, pulmonary vascular resistance, capillary wedge pressure, and cardiac index were also obtained at baseline in all patients. Outcome was defined as mortality because of cardiovascular-related death. The study cohort comprised 777 patients (514 women) with precapillary pulmonary hypertension. A total of 195 (25%) died. In multivariable analysis, moderate or severe tricuspid regurgitation (hazard ratio [HR], 26.537; 95% confidence interval, 11.536-61.044; P<0.001), right ventricular myocardial performance index (HR, 3.421; 95% confidence interval, 1.777-6.584; P<0.001), and the presence of pericardial effusion (HR, 1.38; 95% confidence interval, 1.023-1.862; P=0.035) were independent predictors of mortality. High pulmonary vascular resistance and right atrial pressure by invasive hemodynamic measurements were independent predictors of mortality (HR, 1.084; 95% confidence interval, 1.041-1.130, and 1.079, respectively; 95% confidence interval, 1.049-1.111; P<0.001 for both), whereas patients with a higher cardiac index had better survival overall (HR, 0.384; 95% confidence interval, 0.307-0.481; P<0.001).
CONCLUSIONS: Right ventricular dysfunction, moderate-severe tricuspid regurgitation, low cardiac index, and raised right atrial pressure were associated with poor survival for both pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensive disease patients. The severity of tricuspid regurgitation, myocardial performance index, presence of pericardial effusion, pulmonary vascular resistance, cardiac index, and right atrial pressure may be used to stratify risk of death.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  echocardiography; pericardial effusion; pulmonary hypertension; right ventricular function; survival analysis

Mesh:

Year:  2015        PMID: 26063743     DOI: 10.1161/CIRCIMAGING.114.002107

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  14 in total

Review 1.  The role of imaging in pulmonary hypertension.

Authors:  Meenal Sharma; Andrew T Burns; Kelvin Yap; David L Prior
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

2.  Noninvasive model including right ventricular speckle tracking for the evaluation of pulmonary hypertension.

Authors:  Yossra Mahran; Robert Schueler; Marcel Weber; Carmen Pizarro; Georg Nickenig; Dirk Skowasch; Christoph Hammerstingl
Journal:  World J Cardiol       Date:  2016-08-26

3.  Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.

Authors:  Tim Lahm; Ivor S Douglas; Stephen L Archer; Harm J Bogaard; Naomi C Chesler; Francois Haddad; Anna R Hemnes; Steven M Kawut; Jeffrey A Kline; Todd M Kolb; Stephen C Mathai; Olaf Mercier; Evangelos D Michelakis; Robert Naeije; Rubin M Tuder; Corey E Ventetuolo; Antoine Vieillard-Baron; Norbert F Voelkel; Anton Vonk-Noordegraaf; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

4.  Benefits from the correction of vitamin D deficiency in patients with pulmonary hypertension.

Authors:  Ahmad Mirdamadi; Pouya Moshkdar
Journal:  Caspian J Intern Med       Date:  2016

5.  Pulmonary arterial hemodynamic assessment by a novel index in systemic lupus erythematosus patients: pulmonary pulse transit time.

Authors:  Tolga Han Efe; Mehmet Doğan; Cem Özişler; Tolga Çimen; Mehmet Ali Felekoğlu; Ahmet Göktuğ Ertem; Engin Algül; Sadık Açıkel
Journal:  Anatol J Cardiol       Date:  2017-06-22       Impact factor: 1.596

6.  Predictors of poor outcome in patients with pulmonary arterial hypertension: A single center study.

Authors:  Emilia Stepnowska; Ewa Lewicka; Alicja Dąbrowska-Kugacka; Ludmiła Daniłowicz-Szymanowicz; Paweł Zagożdżon; Rafał Kamiński; Zuzanna Lewicka-Potocka; Paweł Miękus; Dariusz Kozłowski; Wojciech Potocki; Grzegorz Raczak
Journal:  PLoS One       Date:  2018-04-23       Impact factor: 3.240

7.  Deep learning cardiac motion analysis for human survival prediction.

Authors:  Ghalib A Bello; Timothy J W Dawes; Jinming Duan; Carlo Biffi; Antonio de Marvao; Luke S G E Howard; J Simon R Gibbs; Martin R Wilkins; Stuart A Cook; Daniel Rueckert; Declan P O'Regan
Journal:  Nat Mach Intell       Date:  2019-02-11

8.  Echocardiographic assessment of pulmonary arterial capacitance predicts mortality in pulmonary hypertension.

Authors:  Alexander Papolos; Geoffrey H Tison; Jacob Mayfield; Elena Vasti; Teresa DeMarco
Journal:  J Cardiol       Date:  2020-11-04       Impact factor: 3.159

9.  Myocardial performance index correlates with the BODE index and affects quality of life in COPD patients.

Authors:  Daniela Graner Schuwartz Tannus-Silva; João Batista Masson-Silva; Lays Silva Ribeiro; Marcus Barreto Conde; Marcelo Fouad Rabahi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-16

10.  Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography.

Authors:  Daniel X Augustine; Lindsay D Coates-Bradshaw; James Willis; Allan Harkness; Liam Ring; Julia Grapsa; Gerry Coghlan; Nikki Kaye; David Oxborough; Shaun Robinson; Julie Sandoval; Bushra S Rana; Anjana Siva; Petros Nihoyannopoulos; Luke S Howard; Kevin Fox; Sanjeev Bhattacharyya; Vishal Sharma; Richard P Steeds; Thomas Mathew
Journal:  Echo Res Pract       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.